Kamada Ltd
KMDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001567529
In the last 90 days, Kamada Ltd insiders filed 0 open-market purchases and 2 sales; 51 institutions reported holding it in 13F filings for Q2 2026, worth $36.7M in total; ARK Invest is the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Kamada Ltd insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 2 filings
- 1 insider, $1.65M in total
- Insiders trading
- 1
- Net value
- −$1.65M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Kamada Ltd, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| London Amir | Chief Executive Officer | – | Sep 25, 2026 | 2 |
| Gorelik Boris | VP, BD and Strategic Programs | – | Sep 24, 2026 | 2 |
| Payorski Lilach | Director | – | Sep 24, 2026 | 3 |
| Reshef Liron | VP Human Resources | – | Sep 24, 2026 | 2 |
| Goldwasser Karnit | Director | – | Sep 24, 2026 | 3 |
| Beladev Shavit | VP Plasma Operations | – | Sep 24, 2026 | 2 |
| Livneh Nir | VP, General Counsel | 0 | Sep 23, 2026 | 3 |
| Pinchuk Orit | VP Regulatory Affairs | – | Sep 23, 2026 | 2 |
| Recanati Leon | Director | – | Sep 23, 2026 | 3 |
| Orlev Chaime | Chief Financial Officer | – | Sep 23, 2026 | 2 |
| Nir Eran | VP, Operations | – | Sep 23, 2026 | 2 |
| Itshayek Assaf | Director | – | Sep 23, 2026 | 3 |
| Dekel Benjamin | Director | – | Sep 23, 2026 | 3 |
| Neheman Hanni | VP, Marketing & Sales | – | Sep 23, 2026 | 2 |
| Brenner Yael | VP Quality | 6,266 | Sep 23, 2026 | 5 |
| Tsur David | Director | 407,929 | Sep 23, 2026 | 6 |
| Botzer Uri | Director | – | Aug 6, 2026 | 1 |
| Asher-Topilsky Lilach | Director | – | Aug 6, 2026 | 1 |
| Davidi Ishay | Director, 10% Owner | – | Aug 6, 2026 | 2 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 (view filing)11:33 AM ET | Sep 14 | 3 daysLate | Tsur DavidDirector | SSale | −22.8K | $8.18 | −$186.7K | −5.3%407.9K after | |
| Sep 11, 2026 (view filing)11:29 AM ET | Sep 7-9 | 4 daysLate | Tsur DavidDirector | SSale | −177.2K | $8.26 | −$1.46M | −29.1%430.8K after | 3 lots |